Diversification of the most gunpowder varieties br

  • Detail

Diversification of drug types brings diversification of drug packaging materials forms

in recent years, China's drug market has grown rapidly, and all enterprises attach great importance to the packaging of drugs. The GDP of the pharmaceutical packaging industry has accounted for more than 10% of the GDP of the national packaging industry. Today, with the emergence of new products and new drug dosage forms, China's pharmaceutical packaging material industry has a huge market space and broad prospects. In short, drug packaging material is the abbreviation of packaging materials and containers directly connected with acceleration signal-to-noise ratio and total root mean square value of in band and out band acceleration. It and the packaged drugs form a complete listed drug, which affects the stability, safety and quality of listed drugs within the validity period to a certain extent. Pharmaceutical packaging materials belong to the category of pharmaceutical packaging. With the rapid development of social economy, the pharmaceutical packaging industry is becoming more and more mature. The diversification of drug types also brings diversification to the forms of pharmaceutical packaging, and accelerates the development of pharmaceutical packaging industry. Compared with foreign countries, the production level of drug packaging materials in China is obviously still in the primary stage: the dosage of drugs is lack of accuracy, and there is a lack of drug packaging for children; The drug package is rough and inconvenient to access; Lack of safety in the packaging of drugs under special management, such as poison, hemp, essence and radiation; The minimum package of drugs is too large, which is not suitable for clinical use and other common problems, which greatly reduces the overall value of drugs. To achieve multi-channel financing, it is obvious that at present, the contribution rate of pharmaceutical packaging materials to the pharmaceutical industry in China is low: in developed countries, pharmaceutical packaging has accounted for about 30% of the value of drugs, while this proportion in China is less than 10%. At present, 65% of China's pharmaceutical packaging level is still behind the world average level in the 1980s, and there is considerable room for growth. In addition, new dosage forms of drugs are emerging one after another, while the matching drug packaging materials are still slow to follow up, and the market potential is huge. With the continuous efforts of relevant departments and the pharmaceutical industry, China's drug regulatory regulations and drug standards have been continuously improved, and gradually achieved international standards. At present, the state is also strengthening the development of pharmaceutical packaging materials industry, and most projects have been listed in the catalogue of industrial products and technologies that the State encourages to develop. This has also prompted major enterprises to move to the high-end market, introduce foreign advanced production lines, speed up the progress of technological development, and complete the upgrading of various pharmaceutical packaging materials

this article comes from the Internet, and the copyright belongs to the original author. It is only for everyone to share and learn. If the author believes that infringement is involved, because China's extruder products are closely linked to strategic new industries, please contact us, and we will delete it immediately after verification

Copyright © 2011 JIN SHI